financetom
Business
financetom
/
Business
/
Pharma will cover up revenue drop of oil well sector: Chemcon Speciality
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pharma will cover up revenue drop of oil well sector: Chemcon Speciality
Oct 20, 2020 8:08 AM

“We will be having a cash surplus in the coming time and the cost of finance will be nullified using finance available to us from the IPO proceeds,” said Kamalkumar Aggarwal, CMD of Chemcon Speciality Chemicals in an interview to CNBC-TV18.

On SEBI settlement case, he said, “Within this week it will be settled; the matter will be taken care by the promoters. It has nothing to do with the company.”

Speaking about business, Aggarwal said the oil well chemical business has been impacted drastically due to decline in oil and gas business.

“Oil well sector revenue drop would be covered up by the pharma sector; it would be balanced up and margins would also be taken care of,” he added.

For more, watch the video

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Esperion Therapeutics Signs Licensing Deal for Nexletol, Nexlizet in Israel
Esperion Therapeutics Signs Licensing Deal for Nexletol, Nexlizet in Israel
Dec 12, 2024
09:47 AM EST, 12/12/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said Thursday it has signed a licensing deal with Neopharm Israel for the exclusive rights to commercialize cholesterol medications Nexletol and Nexlizet in Israel. Under the terms of the agreement, Esperion will grant Neopharm exclusive commercialization rights to the drugs in Israel, Gaza, and the West Bank. In...
Aptevo Therapeutics Shares Rally After Trial Results Show Complete Remission by Acute Myeloid Leukemia Patients
Aptevo Therapeutics Shares Rally After Trial Results Show Complete Remission by Acute Myeloid Leukemia Patients
Dec 12, 2024
09:49 AM EST, 12/12/2024 (MT Newswires) -- Aptevo Therapeutics ( APVO ) shares were surging early Thursday after the company said all of the patients with acute myeloid leukemia treated with its mipletamig bispecific antibody achieved remission within 30 days of treatment in a phase 1b trial, including two patients in the cohort who experienced complete remission with 100% elimination...
Canadian Pacific Kansas City, Americold Realty Trust to Explore Project Opportunities in Mexico
Canadian Pacific Kansas City, Americold Realty Trust to Explore Project Opportunities in Mexico
Dec 12, 2024
09:46 AM EST, 12/12/2024 (MT Newswires) -- Canadian Pacific Kansas City ( CP ) (CP, CP.TO) and Americold Realty Trust ( COLD ) said Thursday that they will formally explore co-development opportunities in Mexico under their collaboration to optimize temperature-sensitive logistics between the US, Mexico and Canada. The companies formed the collaboration last year and broke ground on their planned...
Archer Aviation, Anduril Industries Collaborate to Develop Hybrid VTOL Aircraft
Archer Aviation, Anduril Industries Collaborate to Develop Hybrid VTOL Aircraft
Dec 12, 2024
09:46 AM EST, 12/12/2024 (MT Newswires) -- Archer Aviation ( ACHR ) said Thursday it is collaborating with Anduril Industries to co-develop a hybrid verticle take-off and landing aircraft for defense applications, for a potential US Department of Defense initiative. Financial details weren't disclosed. To advance this initiative Archer raised $430 million in equity funding from Stellantis ( STLA )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved